Vergoeding 2019-2023 voor ATC-subgroep L01X : Overige oncolytica
- Raming voor de totale Zvw-populatie
2019 | 2020 | 2021 | 2022* | 2023* | |
---|---|---|---|---|---|
L01XA Platinaverbindingen | 1.709.013 | 2.012.992 | 2.808.122 | 2.213.021 | 2.113.480 |
L01XB Methylhydrazinen | 133.624 | 122.922 | 124.321 | 131.986 | 122.481 |
L01XD Sensitizers bij fotodynamische en radiotherapie | 1.454.511 | 956.894 | 931.632 | 655.919 | 601.649 |
L01XF Retinoiden bij kanker | 152.629 | 209.270 | 183.111 | 147.417 | 250.358 |
L01XG Proteasoomremmers | 43.323.596 | 33.075.439 | 26.329.043 | 19.910.267 | 20.188.559 |
L01XH Hdac-remmers | . | 4.699 | . | . | . |
L01XJ Hedgehog-signaalroute remmers | 657.715 | 725.718 | 845.785 | 951.287 | 1.367.636 |
L01XK Parp-remmers | 10.834.247 | 16.125.747 | 28.464.397 | 32.792.264 | 30.598.591 |
L01XL Oncolytische cel- en gentherapie | 7.892.580 | 20.734.513 | 27.514.784 | 37.756.222 | 33.053.260 |
L01XX Overige oncolytica | 11.154.627 | 14.744.873 | 18.246.505 | 20.879.834 | 24.529.749 |
L01XY Combinaties van oncolytica | 221.052 | 90.008 | 749.083 | 384.126 | 345.183 |
Totaal | 77.533.594 | 88.803.077 | 106.196.781 | 115.822.343 | 113.170.944 |